Home > Research > Browse

Results for Insulin

Publications & Outputs

  1. Neuroprotective effects of the novel GLP-1 long acting analogue semaglutide in the MPTP Parkinson's disease mouse model

    Zhang, L., Zhang, L., Li, L. & Hölscher, C., 10/2018, In : Neuropeptides. 71, p. 70-80 11 p.

    Research output: Contribution to journalJournal article

  2. Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Alzheimer's and Parkinson's disease models

    Hölscher, C., 1/07/2018, In : Neuropharmacology. 136, Part B, p. 251-259 9 p.

    Research output: Contribution to journalJournal article

  3. Two novel dual GLP-1/GIP receptor agonists are neuroprotective in the MPTP mouse model of Parkinson's disease

    Feng, P., Zhang, X., Li, D., Ji, C., Yuan, Z., Wang, R., Xue, G., Li, G. & Hölscher, C., 1/05/2018, In : Neuropharmacology. 133, p. 385-394 10 p.

    Research output: Contribution to journalJournal article

  4. Post-treatment with the GLP-1 analogue liraglutide alleviate chronic inflammation and mitochondrial stress induced by Status epilepticus

    Wang, R-F., Xue, G-F., Hölscher, C., Tian, M-J., Feng, P., Zheng, J-Y. & Li, D-F., 05/2018, In : Epilepsy Research. 142, p. 45-52 8 p.

    Research output: Contribution to journalJournal article

  5. Neuroprotective effects of a triple GLP-1/GIP/glucagon receptor agonist in the APP/PS1 transgenic mouse model of Alzheimer's disease

    Tai, J., Liu, W., Li, Y., Li, L. & Hölscher, C., 1/01/2018, In : Brain Research. 1678, p. 64-74 11 p.

    Research output: Contribution to journalJournal article

  6. FGF21 Is an Insulin-Dependent Postprandial Hormone in Adult Humans

    Samms, R. J., Lewis, J. E., Norton, L., Stephens, F. B., Gaffney, C. J., Butterfield, T., Smith, D. P., Cheng, C. C., Perfield, J. W., Adams, A. C., Ebling, F. J. P. & Tsintzas, K., 1/10/2017, In : Journal of Clinical Endocrinology and Metabolism. 102, 10, p. 3806-3813 8 p.

    Research output: Contribution to journalJournal article

  7. A novel GLP-1/GIP dual receptor agonist protects from 6-OHDA lesion in a rat model of Parkinson's disease

    Jalewa, J., Sharma, M. K., Gengler, S. & Hölscher, C., 1/05/2017, In : Neuropharmacology. 117, p. 238-248 11 p.

    Research output: Contribution to journalJournal article

  8. A novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinson′s disease by increasing expression of BNDF

    Ji, C., Xue, G-F., Lijun, C., Feng, P., Li, D., Li, L., Li, G. & Holscher, C., 1/03/2016, In : Brain Research. 1634, p. 1-11 11 p.

    Research output: Contribution to journalJournal article

  9. Neuroprotective effects of a GIP analogue in the MPTP Parkinson's disease mouse model

    Li, Y., Liu, W., Li, L. & Holscher, C., 02/2016, In : Neuropharmacology. 101, p. 255-263 9 p.

    Research output: Contribution to journalJournal article

  10. Neuroprotective effects of (Val8)GLP-1-Glu-PAL in the MPTP Parkinson's disease mouse model

    Zhang, Y., Chen, Y., Li, L. & Holscher, C., 15/10/2015, In : Behavioural Brain Research. 293, p. 107-113 7 p.

    Research output: Contribution to journalJournal article

  11. Neuroprotective effects of an oxyntomodulin analogue in the MPTP mouse model of Parkinson's disease

    Liu, W., Li, Y., Jalewa, J., Saunders-Wood, T., Li, L. & Hölscher, C., 2015, In : European Journal of Pharmacology. 765, p. 284-290 7 p.

    Research output: Contribution to journalJournal article

More results »